Join DS2 at LSX Congress USA 2026
DS2 will be at LSX Congress USA in Boston on September 23 and 24, in the partnering and commercialization tracks and meeting customers and partners around the sessions. Put a time in with us.
Let's Connect in Boston
LSX Congress USA brings more than 1,000 senior attendees together with 300 investors, 180 speakers and around 2,000 one-to-one partnering meetings. Biotech founders and chief executives, business development leads from AbbVie, GSK, Merck, Novartis, Takeda and AstraZeneca, and the investors funding the next round are all in the building. We provide industry-leading solutions across the entire connected sample supply chain, and that is a capability question most of these companies reach sooner than they expect. If you are preparing to move a programme into the clinic, expand into a new market, or show a partner that your operational plan holds up, we're looking forward to talking about how kitting, distribution, courier, cold chain, biostorage and integration would be set up behind it. Bring the stage you are at and we'll talk through what it takes to scale.
We often find during these events that the diary fills up quickly. Use the form and we'll block a time for you to meet our team while availability lasts.
Why Attend LSX Congress USA 2026?
LSX positions the Congress as "Powering Biotech Growth Through Capital and Pharma Partnerships," bringing biotech founders and executives together with active investors and pharma partnering leaders for funding conversations, strategic partnerships and business growth.
The published numbers: The published numbers are 1,000 or more senior attendees, 300 investors, 180 expert speakers and 2,000 one-to-one partnering meetings, with a structure built around targeted meetings, company showcases and content aimed at biotech priorities.
Four tracks in parallel: Four tracks run through the Congress: Early Innovation & Technology Translation, Capital Markets & Investment Strategies, Pharma Partnering & Deal Making, and Market Opportunities & Commercialisation, alongside keynote plenaries on emerging trends.
A Day 0 of Forums: A Day 0 of Forums runs on September 22, covering a Biotech CEO Forum, a Master Forum on partnering with China, a Pharma Partnering Workshop and a Fundraising Workshop. Note that the Biotech Week Boston umbrella page lists LSX as September 22 to 24 while the LSX site puts the Congress on September 23 and 24 with Forums on September 22.
Why Meet with DS2?
Partnering conversations move quickly from the science to whether the plan behind it holds up. How the samples get collected, how they travel, how the chain of custody is documented and how the data comes back are all part of that answer. DS2 builds and runs that layer for sponsors of every size, and it is a useful thing to have settled before a diligence call rather than during one. What we do:
- Diagnostic and specimen collection kit design, assembly and fulfillment
- Kit-to-patient and direct-to-patient distribution
- Medical courier services, including STAT and next-flight-out specimen transport
- Cold chain and temperature-controlled logistics, with the documentation to prove the range held
- Biostorage and biorepository services
- Mobile phlebotomy and specimen collection
- LIS, LIMS and EMR integration, including HL7 and FHIR
- Chain of custody and compliance documentation
Kitting, distribution, courier, cold chain, biostorage and integration, set up so the operational story matches the scientific one. We're excited to talk it through in Boston.
Speaking Faculty
A selection from the 180 speakers published for 2026.
Rachel Strick
AbbVie
Vice President, Business Development and Acquisitions
Kiran Reddy
Blackstone Life Sciences
Senior Managing Director
Scott DeWire
Boehringer Ingelheim
Corporate Senior Vice President and Head of Global Business Development
Evan Lippman
Teva Pharmaceuticals
Executive Vice President, Business Development
Jennifer Schranz
Ipsen
Senior Vice President, Global Head of Rare Diseases
Renee Aguiar-Lucander
Hansa Biopharma
Chief Executive Officer
Tomoko Hanadate
Astellas Pharma
Head of R&D Alliances, Business Development
Christopher Tan
Merck & Co.
Executive Director, BD&L
Elena Diez Cecilia
Johnson & Johnson
Senior Director, External Innovation DPDS
Curt LaBelle
BNP Paribas Asset Management
Managing Partner and Head, AXA IM Global Health Investment Fund
Mike Patten
Harbour BioMed
Chief Strategy Officer
Scott Miller
Eli Lilly
Executive Director, Alliance and Innovation Management
The full speaker list is on the official speakers page.
The Agenda, Day by Day
Times below are as published by LSX. Four tracks run in parallel through both Congress days, so the listing picks out the plenaries and a representative sweep of each track. The full agenda, including all four tracks and the showcase programme, is on the official agenda pages.
Tuesday, September 22 · Day 0 Forums
Arrival and registration
Biotech CEO Forum
Jillian Shapiro, Fish & Richardson; Kieran Engels, Seuss+; Aaron Schuchart, Aether Therapeutics; Limor Ben Har, Prilenia; Ross Pettit, Kestrel Therapeutics
Master Forum: Partnering with China
Jim Wu, SaniMed Science Group; Claris Tsang Munksgaard, EMD Serono; William Pay, HK WinHealth Pharma Group; David Young, Consun Pharmaceutical Group
Networking break
Pharma Partnering Workshop
Kasper Veje, Novo Nordisk; Mike Jones, Takeda; Matt Karlyn, A&O Shearman; John Dyer, Aquilo Partners
Fundraising Workshop
Michael Salgaller, National Institutes of Health; Prativa Joshi, imec
Close of Day 0
Wednesday, September 23 · Day One
Breakfast, registration and first-timer orientation
Adam Griffiths, Portfolio Manager, Partnering and Investment, Informa Connect
Keynote plenary: Shaping the Future of Biopharma, Global Investment and Innovation
Brian Goodman, Vida Ventures; Craig Kenesky, Brown Rudnick; Debra Yu, Panacea Capital; Curt LaBelle, BNP Paribas Asset Management
Keynote plenary: Emerging Modalities and Therapeutic Frontiers
Jessica Federer, Angelini Ventures; Fiona Miller, quadraScope Ventures; Fei Shen, Boehringer Ingelheim Venture Fund
Morning break
Four parallel tracks
Bench to bedside translation; venture capital trends; global biopharma partnerships and out-licensing; breaking into new markets
Lunch break
Four parallel tracks
Financing translation-ready biotechs; biotech IPOs in 2026; digital health in partnerships; commercializing rare disease therapies
Speed networking and afternoon break
Keynote plenary: Signal over Noise, Crafting Investable Science in Shifting Markets
John Swart, Cytotheryx; Soyoung Park, 1004 Venture Partners; Aryeh Ganz, Cornucopian Capital; Elizabeth Bailey, Foreground Capital
Keynote plenary: Case Studies in Successful Biopharma M&A
Derrick Lott, A&O Shearman; Scott DeWire, Boehringer Ingelheim; Rachel Strick, AbbVie
Biotech Week Boston drinks reception
Thursday, September 24 · Day Two
Registration, breakfast and welcome address
Keynote plenary: The Art of the Deal, Structuring Successful Biopharma Partnerships
Evan Lippman, Teva Pharmaceuticals; Frederic Scaerou, Servier; Sergio Davila, Acadia Pharmaceuticals
Keynote plenary: The Role of Private Equity in Scaling Biopharma Companies
Kiran Reddy, Blackstone Life Sciences; Kyle Faget, McDermott Will & Schulte
Morning break
Four parallel tracks
Next frontier therapeutics in RNA and antibodies; building the executive bench; aligning scientific, commercial and financial goals; commercialization strategy for first-in-class therapies
Four parallel tracks
Incubators and accelerators; macroeconomic trends in biotech investment; academic-industry partnerships; commercial pitching
Lunch break
Keynote plenary: AI-Native Biotech, What Investors Want and What Builders Need
Michelle Chen, Form Bio; Jana Jensen, Excelsior Sciences; Navin Govind, Evidence Ventures; David Steinberg, Formation Bio
Keynote plenary: Beyond the Horizon, Biotech's Next Decade of Impact and Returns
Urvashi Bhatnagar, The Good Science Fund; Elena Itskovich, Nest Catalyst Ventures; Sally Wang Liang, Xpanse Venture
Close of Day 2 and drinks reception
Useful LSX Congress USA Resources
The official event page.
Day 1 AgendaSeptember 23, across all four tracks.
Day 2 AgendaSeptember 24, across all four tracks.
SpeakersThe published faculty.
TicketsPass types and eligibility.
PartneringONEHow one-to-one meetings are arranged.
Investor CriteriaWho qualifies for investor registration.
Plan Your VisitTravel and venue information.
FloorplanThe exhibition hall layout.
LSX Congress USA 2026 FAQ
General
Registration and Travel
See You in Boston
Boston, September 23 and 24. Send a line on where your programme is heading and we'll find a slot to talk about the supply chain that has to carry it.